查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1500098

呼吸診斷市場-全球產業規模、佔有率、趨勢、機會和預測，按類型、測試類型、疾病適應症、最終用途、地區和競爭細分，2019-2029F

Respiratory Diagnostics Market- Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type, By Test Type, By Disease Indication, By End-Use, By Region and Competition, 2019-2029F
出版日期: | 出版商: TechSci Research | 英文 185 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

2023 年全球呼吸診斷市場估值為57.1 億美元，預計在預測期內穩定成長，到2029 年複合年成長率為6.73%。關重要的領域，受到呼吸系統疾病日益流行以及對早期準確診斷解決方案日益重視的推動。該市場涵蓋各種旨在評估和監測呼吸系統疾病的診斷工具和設備，包括慢性阻塞性肺病（COPD）、氣喘和呼吸道感染。推動市場的主要促進因素包括空氣污染、菸草使用和人口老化等因素導致的全球呼吸道疾病負擔不斷增加。技術進步在塑造呼吸診斷領域發揮關鍵作用，其創新範圍從先進的成像技術到分子診斷和快速即時檢測。這些技術使醫療保健專業人員能夠更有效地診斷呼吸系統疾病，促進及時干預和個人化治療計劃。

市場概況
預測期 2025-2029
2023 年市場規模 57.1億美元
2029 年市場規模 83.6億美元
2024-2029 年複合年成長率 6.73%
成長最快的細分市場 測定和試劑
最大的市場 北美洲

人們對早期診斷和疾病管理重要性的認知不斷提高，促使呼吸系統診斷的需求激增。患者和醫療保健提供者都認知到在發病時識別呼吸系統疾病的重要性，從而可以採取積極措施來減緩疾病的進展並改善患者的治療結果。全球 COVID-19 大流行進一步凸顯了呼吸診斷的關鍵作用，推動了檢測方法和基礎設施的快速發展。診斷測試，包括分子測定和血清學測試，對於識別和監測呼吸道感染至關重要，重點是導致 COVID-19 的 SARS-CoV-2 病毒。市場參與者也投資於研發，推出新型診斷解決方案，包括攜帶式和非侵入性設備，促進呼吸系統檢測的分散並提高患者的可及性。此外，診斷公司和醫療機構之間的合作有助於呼吸診斷的不斷發展，帶來創新技術和解決方案。

主要市場促進因素

呼吸道疾病的盛行率

全球人口老化

主要市場挑戰

診斷的複雜性

技術人員的可用性

主要市場趨勢

更重視早期準確診斷

遠距醫療和遠端監控

細分市場洞察

類型洞察

最終用途見解

區域洞察

目錄

第 1 章：產品概述

第 2 章：研究方法

第 3 章：執行摘要

第 4 章：客戶之聲

第 5 章：全球呼吸診斷市場展望

  • 市場規模及預測
    • 按價值
  • 市佔率及預測
    • 按類型（儀器和設備、測定和試劑、服務和軟體）
    • 按測試類型（機械測試、OSA 診斷測試、影像測試、傳統診斷測試、分子診斷測試）
    • 依疾病適應症（結核病、氣喘、肺癌、慢性阻塞性肺病、其他）
    • 依最終用途（醫院和診所、診斷實驗室、其他）
    • 按地區
    • 按公司分類 (2023)
  • 市場地圖
    • 按類型
    • 按測試類型
    • 按疾病適應症
    • 按最終用途
    • 按地區

第 6 章：亞太地區呼吸診斷市場展望

  • 市場規模及預測
    • 按價值
  • 市佔率及預測
    • 按類型
    • 按測試類型
    • 按疾病適應症
    • 按最終用途
    • 按國家/地區
  • 亞太地區：國家分析
    • 中國
    • 印度
    • 澳洲
    • 日本
    • 韓國

第 7 章：歐洲呼吸診斷市場展望

  • 市場規模及預測
    • 按價值
  • 市佔率及預測
    • 按類型
    • 按測試類型
    • 按疾病適應症
    • 按最終用途
    • 按國家/地區
  • 歐洲：國家分析
    • 法國
    • 德國
    • 西班牙
    • 義大利
    • 英國

第 8 章：北美呼吸診斷市場展望

  • 市場規模及預測
    • 按價值
  • 市佔率及預測
    • 按類型
    • 按測試類型
    • 按疾病適應症
    • 按最終用途
    • 按國家/地區
  • 北美：國家分析
    • 美國
    • 墨西哥
    • 加拿大

第 9 章：南美洲呼吸診斷市場展望

  • 市場規模及預測
    • 按價值
  • 市佔率及預測
    • 按類型
    • 按測試類型
    • 按疾病適應症
    • 按最終用途
    • 按國家/地區
  • 南美洲：國家分析
    • 巴西
    • 阿根廷
    • 哥倫比亞

第 10 章：中東和非洲呼吸診斷市場展望

  • 市場規模及預測
    • 按價值
  • 市佔率及預測
    • 按類型
    • 按測試類型
    • 按疾病適應症
    • 按最終用途
    • 按國家/地區
  • MEA：國家分析
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 埃及

第 11 章：市場動態

  • 促進要素
  • 挑戰

第 12 章：市場趨勢與發展

  • 最近的發展
  • 產品發布
  • 併購

第 13 章：全球呼吸診斷市場：SWOT 分析

第 14 章：波特的五力分析

  • 產業競爭
  • 新進入者的潛力
  • 供應商的力量
  • 客戶的力量
  • 替代產品的威脅

第15章：競爭格局

  • Koninklijke Philips NV
  • Beckton, Dickson and Company
  • Thermo Fisher Scientific Inc.
  • Abbott Laboratories Inc.
  • Dragerwerk AG & Co. KGaA
  • Siemens Healthineers AG
  • PerkinElmer Inc.
  • India Medtronic Private Limited
  • Bio-Rad Laboratories, Inc.
  • GE HealthCare Technologies Inc.

第 16 章：策略建議

第17章調查會社について,免責事項

簡介目錄
Product Code: 23927

Global Respiratory Diagnostics Market was valued at USD 5.71 Billion in 2023 and is anticipated to project steady growth in the forecast period with a CAGR of 6.73% through 2029. The Global Respiratory Diagnostics Market has emerged as a dynamic and crucial sector within the broader healthcare industry, driven by the increasing prevalence of respiratory diseases and a growing emphasis on early and accurate diagnostic solutions. This market encompasses a diverse range of diagnostic tools and devices designed to evaluate and monitor respiratory conditions, including chronic obstructive pulmonary disease (COPD), asthma, and respiratory infections. Key drivers propelling the market include the rising global burden of respiratory illnesses, spurred by factors such as air pollution, tobacco use, and an aging population. Technological advancements play a pivotal role in shaping the landscape of respiratory diagnostics, with innovations ranging from advanced imaging techniques to molecular diagnostics and rapid point-of-care testing. These technologies enable healthcare professionals to diagnose respiratory conditions more efficiently, facilitating timely interventions and personalized treatment plans.

Market Overview
Forecast Period2025-2029
Market Size 2023USD 5.71 Billion
Market Size 2029USD 8.36 Billion
CAGR 2024-20296.73%
Fastest Growing SegmentAssays & Reagents
Largest MarketNorth America

The increased awareness of the importance of early diagnosis and disease management has prompted a surge in demand for respiratory diagnostics. Patients and healthcare providers alike recognize the significance of identifying respiratory conditions at their onset, allowing for proactive measures to mitigate the progression of diseases and improve patient outcomes. The global COVID-19 pandemic has further underscored the critical role of respiratory diagnostics, driving rapid developments in testing methodologies and infrastructure. Diagnostic tests, including molecular assays and serological tests, have been pivotal in identifying and monitoring respiratory infections, with a focus on the SARS-CoV-2 virus responsible for COVID-19. Market players are also investing in research and development to introduce novel diagnostic solutions, including portable and non-invasive devices, fostering the decentralization of respiratory testing and enhancing accessibility for patients. Additionally, collaborations between diagnostic companies and healthcare institutions contribute to the continuous evolution of respiratory diagnostics, bringing forth innovative technologies and solutions.

Key Market Drivers

Prevalence of Respiratory Diseases

The prevalence of respiratory diseases serves as a paramount driver for the Global Respiratory Diagnostics Market, underscoring the critical need for accurate and timely diagnostic solutions. Chronic respiratory conditions, such as chronic obstructive pulmonary disease (COPD), asthma, and respiratory infections, have become increasingly prevalent on a global scale. Contributing factors include environmental pollutants, occupational exposures, lifestyle choices, and an aging population. As the incidence of these respiratory ailments continues to rise, the demand for advanced and efficient diagnostic tools becomes imperative for effective disease management. The aging population is particularly susceptible to respiratory issues, and as the demographic landscape shifts towards an older age structure globally, the burden of respiratory diseases intensifies.

Older individuals often experience age-related respiratory conditions, making early detection and diagnosis crucial for implementing timely interventions. Moreover, the growing awareness among individuals regarding the impact of environmental factors on respiratory health drives a proactive approach to seek respiratory diagnostics for preventive healthcare measures. The COVID-19 pandemic has further accentuated the significance of respiratory diagnostics in the context of global respiratory infections. The heightened focus on testing and monitoring respiratory infections has accelerated advancements in diagnostic technologies. Collectively, the prevalence of respiratory diseases acts as a catalyst, propelling the continuous evolution and expansion of the respiratory diagnostics market to meet the increasing demand for precise and efficient diagnostic solutions in the face of the growing respiratory health challenges worldwide.

Global Aging Population

The Global Respiratory Diagnostics Market is significantly influenced by the aging population worldwide. As demographic patterns shift towards an increasingly older populace, the prevalence of respiratory conditions tends to rise, necessitating a heightened focus on respiratory diagnostics. Aging is associated with a higher susceptibility to respiratory ailments, including chronic obstructive pulmonary disease (COPD), pneumonia, and other age-related respiratory issues. The anatomical and physiological changes that accompany aging, such as reduced lung elasticity and weakened respiratory muscles, contribute to an elevated risk of respiratory disorders.

The demand for advanced diagnostic tools becomes more pronounced to facilitate early detection and proactive management of respiratory diseases in the elderly. The aging population's greater vulnerability to respiratory infections, coupled with a potential decline in immune function, underscores the importance of respiratory diagnostics in this demographic. Timely and accurate diagnostic solutions are essential for tailoring effective interventions and optimizing treatment outcomes for elderly individuals with respiratory conditions. The Global Respiratory Diagnostics Market responds to this demographic imperative by continually innovating diagnostic technologies, embracing portability and non-invasiveness, and enhancing accessibility to diagnostic services. As the aging population continues to expand, the market for respiratory diagnostics is poised to play a pivotal role in addressing the unique healthcare challenges associated with respiratory health in older individuals, contributing to improved quality of life and enhanced healthcare outcomes for this demographic segment.

Key Market Challenges

Complexity in Diagnosis

The Global Respiratory Diagnostics Market grapples with the inherent complexity in diagnosing respiratory conditions, presenting a significant challenge to accurate and timely disease identification. Respiratory diseases often exhibit a spectrum of symptoms that can overlap, making it intricate to differentiate between conditions such as asthma, chronic obstructive pulmonary disease (COPD), and respiratory infections solely based on clinical presentation. This complexity necessitates sophisticated and multi-faceted diagnostic approaches, including advanced imaging techniques, molecular diagnostics, and pulmonary function tests. Moreover, the challenge of diagnosing respiratory diseases is compounded by the diversity of potential causes, ranging from environmental factors and occupational exposures to genetic predispositions. The intricate interplay of these variables requires comprehensive diagnostic tools that can discern subtle nuances in disease presentation and etiology.

In addition, the need for differential diagnosis is amplified by the existence of comorbidities, where individuals may concurrently experience multiple respiratory conditions. Unraveling this diagnostic complexity is crucial for tailoring appropriate treatment strategies and interventions. Advanced technologies, such as precision medicine and personalized diagnostics, are increasingly being explored to address the intricate nature of respiratory disease diagnosis by considering individual patient characteristics and genetic factors. As the Global Respiratory Diagnostics Market continues to evolve, the industry faces the ongoing challenge of developing and refining diagnostic tools that can navigate the intricate landscape of respiratory diseases. Overcoming the complexity in diagnosis requires ongoing research, technological innovation, and collaborative efforts to enhance the specificity and sensitivity of diagnostic methods, ultimately improving patient outcomes and optimizing respiratory healthcare delivery.

Availability of Skilled Personnel

The availability of skilled personnel poses a significant challenge to the Global Respiratory Diagnostics Market, impacting the effective implementation and utilization of advanced diagnostic technologies. Operating and interpreting results from sophisticated respiratory diagnostic tools, such as molecular assays, imaging techniques, and pulmonary function tests, often requires specialized training and expertise. However, there is a shortage of healthcare professionals with the necessary skills and proficiency in utilizing these technologies, particularly in resource-limited settings and underserved regions. The complexity of respiratory diseases and the diverse range of diagnostic modalities available further exacerbate the challenge of skilled personnel availability. Healthcare professionals need to possess a comprehensive understanding of respiratory anatomy and physiology, as well as proficiency in interpreting diagnostic results accurately to facilitate timely diagnosis and appropriate treatment decisions.

Staying abreast of advancements in respiratory diagnostics requires continuous education and training, which may not always be readily accessible to healthcare professionals in all regions. Addressing the shortage of skilled personnel in respiratory diagnostics requires concerted efforts from various stakeholders. This includes investing in specialized training programs and continuing education opportunities for healthcare professionals to enhance their diagnostic skills. Collaboration between academic institutions, healthcare organizations, and industry partners can facilitate the development of tailored training programs that address the specific needs of respiratory diagnostics. Also, leveraging telemedicine and digital health platforms can extend the reach of skilled personnel to remote or underserved areas, ensuring broader access to respiratory diagnostic expertise and improving healthcare outcomes for patients worldwide.

Key Market Trends

Increased Emphasis on Early and Accurate Diagnosis

The Global Respiratory Diagnostics Market is witnessing a pronounced trend marked by an increased emphasis on early and accurate diagnosis of respiratory conditions. This shift is driven by a recognition of the substantial benefits associated with timely disease identification, leading to improved patient outcomes and more effective management of respiratory disorders. Advances in diagnostic technologies, including molecular testing, advanced imaging modalities, and novel biomarkers, have facilitated a more precise and rapid diagnosis of respiratory diseases. Early diagnosis is particularly crucial in respiratory health, as it enables healthcare professionals to initiate timely interventions, tailor treatment plans, and prevent the progression of conditions such as asthma, chronic obstructive pulmonary disease (COPD), and respiratory infections. The integration of point-of-care testing, offering quick and convenient diagnostic results, further supports this trend, especially in settings where immediate decision-making is imperative.

The growing understanding of the impact of respiratory diseases on public health has heightened the importance of proactive healthcare measures. Screening programs and routine respiratory diagnostics have become integral components of preventive healthcare strategies. Patients and healthcare providers alike recognize that early detection not only enhances treatment efficacy but also reduces the economic burden associated with advanced-stage respiratory diseases. As the Global Respiratory Diagnostics Market continues to evolve, the increased emphasis on early and accurate diagnosis is expected to drive innovation, encourage research and development, and ultimately contribute to a paradigm shift in respiratory healthcare, fostering a future where proactive diagnostics play a central role in preserving respiratory health worldwide.

Telehealth and Remote Monitoring

Telehealth and remote monitoring have emerged as transformative trends in the Global Respiratory Diagnostics Market, especially accelerated by the paradigm shift induced by the COVID-19 pandemic. These technologies play a pivotal role in reshaping how respiratory diagnostics are conducted, providing opportunities for remote consultations, continuous patient monitoring, and accessible healthcare delivery. The adoption of telehealth platforms facilitates virtual consultations, enabling individuals to connect with healthcare professionals for respiratory assessments without the need for physical visits to medical facilities. This has proven particularly valuable in ensuring continued respiratory care during times of social distancing and lockdowns. Remote monitoring technologies offer a real-time and continuous assessment of respiratory parameters, providing crucial data for the early detection and management of respiratory conditions.

Wearable devices, smart inhalers, and other connected technologies enable healthcare providers to remotely track patients' respiratory health, optimizing personalized treatment plans and improving overall disease management. These innovations not only enhance patient convenience but also contribute to better adherence to treatment regimens and timely interventions. The integration of telehealth and remote monitoring in the respiratory diagnostics landscape not only addresses the challenges posed by geographical barriers but also supports proactive healthcare measures. Patients with chronic respiratory conditions can benefit from regular monitoring and timely adjustments to their treatment plans, reducing the risk of exacerbations and hospitalizations. As the Global Respiratory Diagnostics Market continues to evolve, the synergy between telehealth, remote monitoring, and respiratory diagnostics is poised to redefine patient care, fostering a future where healthcare is increasingly accessible, personalized, and proactive.

Segmental Insights

Type Insights

Based on Type, Assays & Reagents have emerged as fastest growing segment in the Global Respiratory Diagnostics Market in 2023. This is ascribed due to its fundamental role in detecting and analyzing respiratory infections. Assays and reagents form the core components of diagnostic tests, enabling the identification of respiratory pathogens, biomarkers, and specific antibodies. The growing prevalence of respiratory diseases and infections fuels the demand for accurate and efficient diagnostic tools. Ongoing advancements in assay technologies contribute to the segment's dominance, facilitating rapid and precise respiratory diagnostics. The Assays & Reagents segment's central role in enhancing diagnostic capabilities positions it as a key driver, influencing the trajectory of the Global Respiratory Diagnostics Market.

End-Use Insights

Based on End-Use, Hospitals and Clinics have emerged as dominating segment in the Global Respiratory Diagnostics Market in 2023. Hospitals and clinics play a pivotal role as primary destinations for individuals seeking respiratory diagnostic services. Patients frequently rely on these healthcare facilities for initial evaluation, diagnosis, and treatment of respiratory conditions, resulting in a significant demand for diagnostic tests. By offering comprehensive healthcare services, including respiratory diagnostics, within a single location, hospitals and clinics promote convenience, encouraging patients to undergo diagnostic procedures and promptly address respiratory ailments. Moreover, hospitals often feature specialized departments and respiratory care units staffed with skilled healthcare professionals, such as pulmonologists and respiratory therapists. These experts possess the knowledge and proficiency to administer and interpret intricate respiratory diagnostic tests, thereby elevating the standard of care provided.

Regional Insights

Based on Region, North America have emerged as the dominating region in the Global Respiratory Diagnostics Market in 2023. North America's advanced healthcare infrastructure features cutting-edge diagnostic facilities and state-of-the-art medical technologies, enabling early detection and diagnosis of respiratory conditions, thus propelling market expansion. With a notable prevalence of respiratory diseases like asthma, chronic obstructive pulmonary disease (COPD), and lung cancer, the region undergoes extensive diagnostic testing, further solidifying its market dominance. Moreover, North America leads the way in developing and adopting innovative respiratory diagnostic technologies, including advanced imaging methods, molecular diagnostics, and point-of-care testing systems, reinforcing its stronghold in the market.

Key Market Players

Koninklijke Philips N.V

Becton, Dickinson and Company

Thermo Fisher Scientific Inc.

Abbott Laboratories Inc.

Dragerwerk AG & Co. KGaA

Siemens Healthineers AG

PerkinElmer Inc.

India Medtronic Private Limited

Bio-Rad Laboratories, Inc.

GE HealthCare Technologies Inc.

Report Scope:

In this report, the Global Respiratory Diagnostics Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Respiratory Diagnostics Market, By Type:

    Instruments and Devices Assays & Reagents Services & Software

Respiratory Diagnostics Market, By Test Type:

    Mechanical Tests OSA Diagnostic Test Imaging Tests Traditional Diagnostic Test Molecular Diagnostic Test

Respiratory Diagnostics Market, By Disease Indication:

    Tuberculosis Asthma Lung Cancer Chronic Obstructive Pulmonary Disease Others

Respiratory Diagnostics Market, By End-Use:

    Hospitals and Clinics Diagnostics Laboratory Others

Respiratory Diagnostics Market, By Region:

    North America
    • United States
    • Canada
    • Mexico
    Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
    Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    South America
    • Brazil
    • Argentina
    • Colombia
    Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Egypt

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global Respiratory Diagnostics Market.

Available Customizations:

Global Respiratory Diagnostics Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Respiratory Diagnostics Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Type (Instruments and Devices, Assays & Reagents, Services & Software)
    • 5.2.2. By Test Type (Mechanical Tests, OSA Diagnostic Test, Imaging Tests, Traditional Diagnostic Test, Molecular Diagnostic Tests)
    • 5.2.3. By Disease Indication (Tuberculosis, Asthma, Lung Cancer, Chronic Obstructive Pulmonary Disease, Others)
    • 5.2.4. By End-Use (Hospitals and Clinics, Diagnostics Laboratory, Others)
    • 5.2.5. By Region
    • 5.2.6. By Company (2023)
  • 5.3. Market Map
    • 5.3.1. By Type
    • 5.3.2. By Test Type
    • 5.3.3. By Disease Indication
    • 5.3.4. By End-Use
    • 5.3.5. By Region

6. Asia Pacific Respiratory Diagnostics Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Type
    • 6.2.2. By Test Type
    • 6.2.3. By Disease Indication
    • 6.2.4. By End-Use
    • 6.2.5. By Country
  • 6.3. Asia Pacific: Country Analysis
    • 6.3.1. China Respiratory Diagnostics Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Type
        • 6.3.1.2.2. By Test Type
        • 6.3.1.2.3. By Disease Indication
        • 6.3.1.2.4. By End-Use
    • 6.3.2. India Respiratory Diagnostics Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Type
        • 6.3.2.2.2. By Test Type
        • 6.3.2.2.3. By Disease Indication
        • 6.3.2.2.4. By End-Use
    • 6.3.3. Australia Respiratory Diagnostics Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Type
        • 6.3.3.2.2. By Test Type
        • 6.3.3.2.3. By Disease Indication
        • 6.3.3.2.4. By End-Use
    • 6.3.4. Japan Respiratory Diagnostics Market Outlook
      • 6.3.4.1. Market Size & Forecast
        • 6.3.4.1.1. By Value
      • 6.3.4.2. Market Share & Forecast
        • 6.3.4.2.1. By Type
        • 6.3.4.2.2. By Test Type
        • 6.3.4.2.3. By Disease Indication
        • 6.3.4.2.4. By End-Use
    • 6.3.5. South Korea Respiratory Diagnostics Market Outlook
      • 6.3.5.1. Market Size & Forecast
        • 6.3.5.1.1. By Value
      • 6.3.5.2. Market Share & Forecast
        • 6.3.5.2.1. By Type
        • 6.3.5.2.2. By Test Type
        • 6.3.5.2.3. By Disease Indication
        • 6.3.5.2.4. By End-Use

7. Europe Respiratory Diagnostics Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Type
    • 7.2.2. By Test Type
    • 7.2.3. By Disease Indication
    • 7.2.4. By End-Use
    • 7.2.5. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. France Respiratory Diagnostics Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Type
        • 7.3.1.2.2. By Test Type
        • 7.3.1.2.3. By Disease Indication
        • 7.3.1.2.4. By End-Use
    • 7.3.2. Germany Respiratory Diagnostics Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Type
        • 7.3.2.2.2. By Test Type
        • 7.3.2.2.3. By Disease Indication
        • 7.3.2.2.4. By End-Use
    • 7.3.3. Spain Respiratory Diagnostics Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Type
        • 7.3.3.2.2. By Test Type
        • 7.3.3.2.3. By Disease Indication
        • 7.3.3.2.4. By End-Use
    • 7.3.4. Italy Respiratory Diagnostics Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Type
        • 7.3.4.2.2. By Test Type
        • 7.3.4.2.3. By Disease Indication
        • 7.3.4.2.4. By End-Use
    • 7.3.5. United Kingdom Respiratory Diagnostics Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Type
        • 7.3.5.2.2. By Test Type
        • 7.3.5.2.3. By Disease Indication
        • 7.3.5.2.4. By End-Use

8. North America Respiratory Diagnostics Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Type
    • 8.2.2. By Test Type
    • 8.2.3. By Disease Indication
    • 8.2.4. By End-Use
    • 8.2.5. By Country
  • 8.3. North America: Country Analysis
    • 8.3.1. United States Respiratory Diagnostics Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Type
        • 8.3.1.2.2. By Test Type
        • 8.3.1.2.3. By Disease Indication
        • 8.3.1.2.4. By End-Use
    • 8.3.2. Mexico Respiratory Diagnostics Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Type
        • 8.3.2.2.2. By Test Type
        • 8.3.2.2.3. By Disease Indication
        • 8.3.2.2.4. By End-Use
    • 8.3.3. Canada Respiratory Diagnostics Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Type
        • 8.3.3.2.2. By Test Type
        • 8.3.3.2.3. By Disease Indication
        • 8.3.3.2.4. By End-Use

9. South America Respiratory Diagnostics Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Type
    • 9.2.2. By Test Type
    • 9.2.3. By Disease Indication
    • 9.2.4. By End-Use
    • 9.2.5. By Country
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil Respiratory Diagnostics Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Type
        • 9.3.1.2.2. By Test Type
        • 9.3.1.2.3. By Disease Indication
        • 9.3.1.2.4. By End-Use
    • 9.3.2. Argentina Respiratory Diagnostics Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Type
        • 9.3.2.2.2. By Test Type
        • 9.3.2.2.3. By Disease Indication
        • 9.3.2.2.4. By End-Use
    • 9.3.3. Colombia Respiratory Diagnostics Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Type
        • 9.3.3.2.2. By Test Type
        • 9.3.3.2.3. By Disease Indication
        • 9.3.3.2.4. By End-Use

10. Middle East and Africa Respiratory Diagnostics Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Type
    • 10.2.2. By Test Type
    • 10.2.3. By Disease Indication
    • 10.2.4. By End-Use
    • 10.2.5. By Country
  • 10.3. MEA: Country Analysis
    • 10.3.1. South Africa Respiratory Diagnostics Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Type
        • 10.3.1.2.2. By Test Type
        • 10.3.1.2.3. By Disease Indication
        • 10.3.1.2.4. By End-Use
    • 10.3.2. Saudi Arabia Respiratory Diagnostics Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Type
        • 10.3.2.2.2. By Test Type
        • 10.3.2.2.3. By Disease Indication
        • 10.3.2.2.4. By End-Use
    • 10.3.3. UAE Respiratory Diagnostics Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Type
        • 10.3.3.2.2. By Test Type
        • 10.3.3.2.3. By Disease Indication
        • 10.3.3.2.4. By End-Use
    • 10.3.4. Egypt Respiratory Diagnostics Market Outlook
      • 10.3.4.1. Market Size & Forecast
        • 10.3.4.1.1. By Value
      • 10.3.4.2. Market Share & Forecast
        • 10.3.4.2.1. By Type
        • 10.3.4.2.2. By Test Type
        • 10.3.4.2.3. By Disease Indication
        • 10.3.4.2.4. By End-Use

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Recent Developments
  • 12.2. Product Launches
  • 12.3. Mergers & Acquisitions

13. Global Respiratory Diagnostics Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Product

15. Competitive Landscape

  • 15.1. Koninklijke Philips N.V
    • 15.1.1. Business Overview
    • 15.1.2. Company Snapshot
    • 15.1.3. Products & Services
    • 15.1.4. Financials (In case of listed)
    • 15.1.5. Recent Developments
    • 15.1.6. SWOT Analysis
  • 15.2. Beckton, Dickson and Company
  • 15.3. Thermo Fisher Scientific Inc.
  • 15.4. Abbott Laboratories Inc.
  • 15.5. Dragerwerk AG & Co. KGaA
  • 15.6. Siemens Healthineers AG
  • 15.7. PerkinElmer Inc.
  • 15.8. India Medtronic Private Limited
  • 15.9. Bio-Rad Laboratories, Inc.
  • 15.10. GE HealthCare Technologies Inc.

16. Strategic Recommendations

17. About Us & Disclaimer